This study evaluated the ability of dipyridamole PET myocardial perfusion imaging to detect
coronary collaterals. A previous study showed an association between dipyridamole …

METHODS One hundred and eleven patients underwent rest-stress PET perfusion imaging
and quantitative coronary angiography at the University ofTexas School ofMedicine between …

Background: F-18 labeled BMS747158 is a novel PET myocardial perfusion imaging tracer
that targets mitochondrial complex 1 and is currently undergoing Phase 2 clinical evaluation …

FiGURE 1. Dipyridamole-@ RbPET Imagingat I and 3 mo post anglopiasty and coronary
anglogram in a patient withclinicalreste ricels.(A) One-month PET: short-ads images …

Robust evidence over many years supports the widespread use of pharmacologic rubidium-
82 positron emission tomography (PET) myocardial perfusion imaging (MPI) for noninvasive …

Background—The goal of this study was to evaluate a new 18F-labeled positron-emission
tomography (PET) perfusion tracer, 18F BMS747158-02, for the assessment of myocardial …

In the last decade, myocardial perfusion imaging (MPI) with PET has emerged to play a
pivotal role in the clinical routine process for the detection of hemodynamically significant …

4. Conclusions The presented MR approach reliably identifies patients with anatomically
and hemodynamically signiticant coronary artery stenoses. This is due to the fact, that the …

Myocardial perfusion imaging using positron emission tomography (PET) may be more
accurate for the diagnosis of coronary artery disease (CAD) than conventional imaging. The …

The advent of myocardial perfusion imaging 30 years ago was a major landmark, which
heralded the emergence of the field of nuclear cardiology into clinical practice. Over the …